TUMOR S-PHASE ACTIVITY, NUCLEOTIDE PROFILE AND RNA LEVELS AFTER HEPATIC-ARTERY OCCLUSION AND REPERFUSION IN AN EXPERIMENTAL-MODEL OF SECONDARY LIVER-CARCINOMA

被引:7
作者
WANG, LQ
ROOS, G
ANDERSSON, B
RENFJARD, E
PERSSON, B
STENRAM, U
机构
[1] UNIV LUND HOSP,DEPT SURG,S-22185 LUND,SWEDEN
[2] UNIV LUND HOSP,DEPT PATHOL,S-22185 LUND,SWEDEN
关键词
D O I
10.1002/bjs.1800820735
中图分类号
R61 [外科手术学];
学科分类号
摘要
Rats with carcinoma of the colon implanted into the liver were subjected to hepatic arterial occlusion for 30-120 min. Regrowth of the tumour after reperfusion was evaluated by immunohistological determination of S-phase activity after injection of bromodeoxyuridine. Levels of RNA and nucleotides, and energy charge, were also examined. DNA synthesis was observed in the entire tumour except in necrotic areas of controls and after 30-min ischaemia with 2-h reflow. Almost all tumoral DNA synthesis was abolished by 2 h of ischaemia, except in a few cells in the tumour periphery, which after reperfusion for 22 and 40 h grew into a band-like concentric layer. Levels of energy charge, adenosine, uridine and guanosine 5'-triphosphates, and RNA were unchanged in liver tissue after hepatic arterial occlusion but decreased in the tumour. In conclusion 30 min of ischaemia did not damage the tumour cells substantially. Ischaemia for 2 h seemed able to kill the tumour cells except those in the periphery in areas nourished by the portal vein where tumour regrowth was seen. The liver tissue was not damaged.
引用
收藏
页码:963 / 967
页数:5
相关论文
共 23 条
[11]  
JAKOBSSON B, 1991, BIOMED BIOCHIM ACTA, V50, P1001
[12]   RELATIONSHIP BETWEEN PORTAL VENOUS AND HEPATIC ARTERIAL BLOOD FLOWS - SPECTRUM OF RESPONSE [J].
KAWASAKI, T ;
CARMICHAEL, FJ ;
SALDIVIA, V ;
ROLDAN, L ;
ORREGO, H .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (06) :G1010-G1018
[13]  
MARBER M, 1994, BMJ-BRIT MED J, V308, P1
[14]   RECENT DEVELOPMENTS IN MEASUREMENT OF NUCLEIC ACIDS IN BIOLOGICAL MATERIALS [J].
MUNRO, HN ;
FLECK, A .
ANALYST, 1966, 91 (1079) :78-&
[15]  
PAKU S, 1993, AM J PATHOL, V143, P926
[16]  
PERSSON B, 1990, SURGICAL RES COMMUNI, V9, P163
[17]  
PERSSON BG, 1990, CANCER, V66, P1139, DOI 10.1002/1097-0142(19900915)66:6<1139::AID-CNCR2820660611>3.0.CO
[18]  
2-X
[19]  
ROOS G, 1993, ANTICANCER RES, V13, P635
[20]  
SCOTT JF, 1956, J HISTOCHEM CYTOCHEM, V4, P1